(#) Real-world usage of glucose lowering agents in heart failure patients with type 2 diabetes

被引：0
|
作者：
Martens, Pieter [1 ]
Janssens, Joyce [1 ]
Ramaekers, Jobbe [1 ]
Dupont, Matthias [1 ]
Mullens, Wilfried [1 ]
机构：
[1] Ziekenhuis Oost Limburg, Genk, Belgium
来源：
ACTA CARDIOLOGICA | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [21] Real-World Heart Failure Burden in Thai Patients
    Jiampo, Panyapat
    Tangkittikasem, Thidaporn
    Boonyapiphat, Thanita
    Senthong, Vichai
    Torpongpun, Artit
    CARDIOLOGY AND THERAPY, 2024, 13 (02) : 281 - 297
  • [22] Real-World Heart Failure Burden in Thai Patients
    Panyapat Jiampo
    Thidaporn Tangkittikasem
    Thanita Boonyapiphat
    Vichai Senthong
    Artit Torpongpun
    Cardiology and Therapy, 2024, 13 : 281 - 297
  • [23] Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents
    Chen, Yen-Wen
    Voelker, Jennifer
    Tunceli, Ozgur
    Pericone, Christopher D.
    Bookhart, Brahim
    Durkin, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 401 - 406
  • [24] Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
    Lim, Lee-Ling
    Lau, Eric S. H.
    Cheung, Johnny T. K.
    Chan, Siew Pheng
    Ji, Linong
    Lim, Soo
    Sirinvaravong, Sirinart
    Unnikrishnan, A. G.
    Luk, Andrea O. Y.
    Cortese, Viviana
    Durocher, Alexandra
    Chan, Juliana C. N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 208 - 221
  • [25] Meta-Analysis of Novel Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus Without Pre-existing Heart Failure
    Ahmed, Aymen
    Shahid, Izza
    Siddiqi, Ahmed Kamal
    Ellahi, Aayat
    Shurjeel, Qazi
    Rashid, Ahmed Mustafa
    Maniya, Talha
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 184 - 188
  • [26] Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients
    Malik, M. E.
    Koeber, L.
    Garred, C. H.
    Zahir, D.
    Jensen, J.
    Jensen, M. H.
    Holt, A.
    Andersson, C.
    Fosboel, E.
    Mohamed, A. A.
    Binding, C.
    Mcgettigan, P.
    Schou, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Real-world efficacy data in patients with type 2 diabetes on Semaglutide
    Zitterl, Andreas
    Peric, Slobodan
    Pichler, Maximilian
    Prager, Margarete
    Prager, Rudolf
    Stulnig, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 265 - 265
  • [28] Elderly Latino Patients with Type 2 Diabetes: A Real-World Perspective
    Cagide, Ana L.
    Giunta, Diego H.
    Bader, Giovanni
    Paldanius, Paivi M.
    Mendivil, Carlos O.
    DIABETES, 2016, 65 : A289 - A289
  • [29] Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data
    Henney, Alex E.
    Riley, David R.
    Heague, Megan
    Hydes, Theresa J.
    Anson, Matthew
    Alam, Uazman
    Cuthbertson, Daniel J.
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4665 - 4673
  • [30] Diabetes and contemporary treatment of chronic heart failure in a large real-world heart failure population
    Radhoe, S. P.
    Veenis, J. F.
    Linssen, G. C. M.
    Van der Lee, C.
    Eurlings, L. W. M.
    Kragten, H.
    Al-Windy, N. Y. Y.
    Van der Spank, A.
    Koudstaal, S.
    Brunner-La Rocca, H. P.
    Brugts, J. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 130 - 131
12345